BIO Highlights IP Challenges Around the Globe
By Zachary Brennan -
Published 07 August 2017
As part of an effort to help the US Trade Representative understand and preserve strong intellectual property (IP) protections for US companies, the Biotechnology Innovation Organization (BIO) recently put together a report highlighting challenges worldwide and noting that IP reforms outside the US could improve conditions for exporting biotech products.
Categories: News, Africa, Asia, Middle East, Anvisa, CFDA, Biologics and biotechnology, Drugs, Government affairs
Tags: intellectual property BIO, biopharmaceutical patents, ANVISA, IP protections